Rutgers Pilot for PREDICT- Patient LAB Test
Rutgers Pilot for Pragmatic Return to Effective Dental Infection Control Through Triage and Testing (PREDICT)- Patient LAB Test
2 other identifiers
interventional
11
1 country
1
Brief Summary
A pilot study was initiated to assess feasibility of testing asymptomatic dental patients presenting to the Oral Medicine Clinic at Rutgers School of Dental Medicine for SARS-CoV-2 viral RNA using an FDA approved RT-PCR test for SARS-CoV2- an RNA RT-PCR assay (Accurate Diagnostics)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 31, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 25, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 25, 2021
CompletedFirst Submitted
Initial submission to the registry
October 31, 2022
CompletedFirst Posted
Study publicly available on registry
November 7, 2022
CompletedResults Posted
Study results publicly available
September 13, 2023
CompletedSeptember 22, 2023
September 1, 2023
25 days
October 31, 2022
July 13, 2023
September 13, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Patient Willingness to Participate in the Study
Percentage of 36 patients who were approached to enroll in the study who actually enrolled
Day 1
Willingness/Ability to Follow Through With the Study With Surveys, Triage and Testing
Percentage of patients who complete the study
26 days
Patient Test Completion
Percentage of patients with completed SARS-CoV-2 testing
Day 1
Percentage of Subjects Who Complete Study Activities to Optimize Gap Between Testing and Study Visit
Percentage of subjects completing study activities within the defined optimal window
From initial consent through study completion- approximately 4 weeks
Ease of Complying With Protocol
Number of participants indicating that it was easy to complete the surveys
Day 26
Percent of Patients Who Completed All of the Required Surveys
Percentage of patients participating in the study who completed pre-visit, triage and post-visit surveys
1 week
Study Arms (1)
SARS-CoV-2 testing
OTHERThere is only one arm in this study- the study is a non-randomized pilot. All the subjects will be tested for SARS CoV 2 viral infection as described.
Interventions
Device: Testing for SARS CoV2 RNA- lab-based RNA RT-PCR testing
Eligibility Criteria
You may qualify if:
- Adult 18 years or older; reporting to the Rutgers School of Dental Medicine for a dental visit
You may not qualify if:
- Previous participation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rutgers School of Dental Medicine
Newark, New Jersey, 07103, United States
Related Publications (3)
American Dental Association COVID-19 Toolkit - Update to Office Procedures During COVID-19. https://www.ada.org/-/media/project/ada-organization/ada/ada-org/files/resources/coronavirus/update_to_office_procedures_during_covid19.pdf accessed on November 11, 2021.
BACKGROUNDEstrich CG, Mikkelsen M, Morrissey R, Geisinger ML, Ioannidou E, Vujicic M, Araujo MWB. Estimating COVID-19 prevalence and infection control practices among US dentists. J Am Dent Assoc. 2020 Nov;151(11):815-824. doi: 10.1016/j.adaj.2020.09.005.
PMID: 33071007BACKGROUNDShirazi S, Stanford CM, Cooper LF. Testing for COVID-19 in dental offices: Mechanism of action, application, and interpretation of laboratory and point-of-care screening tests. J Am Dent Assoc. 2021 Jul;152(7):514-525.e8. doi: 10.1016/j.adaj.2021.04.019. Epub 2021 May 4.
PMID: 34176567BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Gayathri Subramanian, PhD, DMD
- Organization
- Rutgers School of Dental Medicine, Newark, New Jersey, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Cecile A Feldman
Rutgers School of Dental Medicine
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
October 31, 2022
First Posted
November 7, 2022
Study Start
January 31, 2021
Primary Completion
February 25, 2021
Study Completion
February 25, 2021
Last Updated
September 22, 2023
Results First Posted
September 13, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
If the COVID test results show that a participant is positive for COVID-19, the study staff will tell the participant the results. The study staff will be required to give the participant's name to the state's Department of Public Health if the participant tests positive because this is the law. At the end of the study, de-identified data will be provided to the National Coordinating Center.